BioStock: Fluicell – pioneers in single-cell technology

Single-cell technology is revolutionizing how diseases are studied and is thus considered one of the top innovations in the biomedical field in recent years. Fluicell, a biotech company located in Mölndal, has been leading in the field since 2012 when it came out with its first product, BioPen, a tool designed for single-cell manipulation. BioStock takes a closer look at why single-cell technologies play an essential role for the future of the healthcare sector.

Read the full article at biostock.se:

https://www.biostock.se/en/fluicell-pioneers-in-single-cell-technology/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se